Zdrowie i gospodarka · 12/08/2026
NIH-Owned Invention Available for License: Soluble Tissue Factor and Antibodies for Thrombosis Diagnosis and Treatment
Scientists at the National Cancer Institute have discovered a novel target for thrombosis, Soluble Tissue Factor, and developed first-in-class antibodies to prevent, diagnose, and treat pathological thrombosis, a condition that can be caused by various clinical conditions such as cancer, sepsis, and heart conditions.